Omega‐3 fatty acids modulate the lipid profile, membrane architecture, and gene expression of leiomyoma cells
article
OA: closed
CC0
⤵ 2 in-corpus citations
AI-generated summary
Omega-3 fatty acids altered lipid profiles and membrane fluidity in myometrial and leiomyoma cells, while decreasing expression of genes related to mechanical signaling and lipid metabolism.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Uterine leiomyomas (fibroids or myomas) are the most common benign tumors of premenopausal women and new medical treatments are needed. This study aimed to determine the effects of omega-3 fatty acids on the lipid profile, membrane architecture and gene expression patterns of extracellular matrix components (collagen1A1, fibronectin, versican, or activin A), mechanical signaling (integrin β1, FAK, and AKAP13), sterol regulatory molecules (ABCG1, ABCA1, CAV1, and SREBF2), and mitochondrial enzyme (CYP11A1) in myometrial and leiomyoma cells. Myometrial tissues had a higher amount of arachidonic acid than leiomyoma tissues while leiomyoma tissues had a higher level of linoleic acid than myometrial tissues. Treatment of primary myometrial and leiomyoma cells with eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA) reduced the monounsaturated fatty acid (MUFA) content and increased the polyunsaturated fatty acid (PUFA) content in both cell types. Myometrial and leiomyoma cell membranes were in the liquid-crystalline phase, but EPA- and DHA-treated cells had decreased membrane fluidity. While we found no changes in the mRNA expression of ECM components, EPA and DHA treatment reduced levels of ABCG1, ABCA1, and AKAP13 in both cell types. EPA and DHA also reduced FAK and CYP11A1 expression in myometrial cells. The ability of omega-3 fatty acids to remodel membrane architecture and downregulate the expression of genes involved in mechanical signaling and lipid accumulation in leiomyoma cells offers to further investigate this compound as preventive and/or therapeutic option.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cited by (2)
References (51)
- W19931880 via openalex
- W643494320 via openalex
- W1859037964 via openalex
- W1972701314 via openalex
- W1973320574 via openalex
- W1978231660 via openalex
- W1986724957 via openalex
- W1986755882 via openalex
- W1987267629 via openalex
- W1990840172 via openalex
- W1993649166 via openalex
- W1997893510 via openalex
- W1998401995 via openalex
- W2002694278 via openalex
- W2007939217 via openalex
- W2022104584 via openalex
- W2023610906 via openalex
- W2028493393 via openalex
- W2029717873 via openalex
- W2038743660 via openalex
- W2045441299 via openalex
- W2050211156 via openalex
- W2067473451 via openalex
- W2067850241 via openalex
- W2069967595 via openalex
- W2077671696 via openalex
- W2082011949 via openalex
- W2088023073 via openalex
- W2093612217 via openalex
- W2094884080 via openalex
- W2099052265 via openalex
- W2110527000 via openalex
- W2113398622 via openalex
- W2113981507 via openalex
- W2120350838 via openalex
- W2121168470 via openalex
- W2121573354 via openalex
- W2144919242 via openalex
- W2163685373 via openalex
- W2170353148 via openalex
- W2180025348 via openalex
- W2264069562 via openalex
- W2511250042 via openalex
- W2569177514 via openalex
- W2602082991 via openalex
- W2626766508 via openalex
- W2889640624 via openalex
- W2963367351 via openalex
- W2964123718 via openalex
- W4255664903 via openalex
- W6681342912 via openalex
Cited by (2)
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK